Literature DB >> 6940194

Clastogenic activity from Bloom syndrome fibroblast cultures.

I Emerit, P Cerutti.   

Abstract

Media from cultures of fibroblasts of six patients with the autosomal recessive disease Bloom syndrome (BS) and from four normal fibroblast strains were analyzed for clastogenic activity towards phytohemagglutinin-stimulated human blood lymphocytes from healthy donors. Clastogenic activity was detected in concentrated ultrafiltrates of media from all six BS strains but none of the normal fibroblast strains. The frequencies of chromosomal aberrations that were induced depended on the concentration of the ultrafiltrates. Addition of bovine superoxide dismutase to the blood lymphocyte cultures strongly suppressed the clastogenic potency of the ultrafiltrates. Unconcentrated conditioned BS media were inactive. From the pore size of the ultrafilters and Sephadex G-10 chromatography it is concluded that the clastogenic material is in the molecular weight range of 1000 to 10,000. The concentrated ultrafiltrates of BS culture media also possessed the capacity to induce sister chromatid exchanges in normal human blood lymphocytes, but with relatively low efficiency. On the basis of these results and by analogy to certain collagen diseases such as systemic lupus erythematosus, we speculate that BS cells are deficient in the detoxification of active oxygen species.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6940194      PMCID: PMC319236          DOI: 10.1073/pnas.78.3.1868

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  26 in total

1.  Defective reactivation of ultraviolet light-irradiated herpesvirus by a Bloom's syndrome fibroblast strain.

Authors:  C A Selsky; P Henson; R R Weichselbaum; J B Little
Journal:  Cancer Res       Date:  1979-09       Impact factor: 12.701

2.  Protease inhibitors antagonize the activation of polymorphonuclear leukocyte oxygen consumption.

Authors:  B D Goldstein; G Witz; M Amoruso; W Troll
Journal:  Biochem Biophys Res Commun       Date:  1979-06-13       Impact factor: 3.575

3.  Normalisation of sister chromatid exchange frequencies in Bloom's syndrome by euploid cell hybridisation.

Authors:  E M Bryant; H Hoehn; G M Martin
Journal:  Nature       Date:  1979-06-28       Impact factor: 49.962

4.  Suppression of the frequencies of sister chromatid exchanges in Bloom's syndrome fibroblasts by co-cultivation with Chinese hamster cells.

Authors:  P P van Buul; A T Natarajan; E A Verdegaal-Immerzeel
Journal:  Hum Genet       Date:  1978-10-31       Impact factor: 4.132

5.  Chromosomal breakage in Crohn's disease: anticlastogenic effect of D-penicillamine and L-cysteine.

Authors:  I Emerit; J Emerit; A Levy; M Keck
Journal:  Hum Genet       Date:  1979       Impact factor: 4.132

6.  The influence of culture medium composition on the incidence of chromosomal breakage.

Authors:  M Keck; I Emerit
Journal:  Hum Genet       Date:  1979-09       Impact factor: 4.132

7.  Effects of mitomycin C on sister chromatid exchange in normal and Bloom's syndrome cells.

Authors:  Y Shiraishi; A A Sandberg
Journal:  Mutat Res       Date:  1978-02       Impact factor: 2.433

8.  Chromosome aberrations and unscheduled DNA synthesis in X- and UV-irradiated lymphocytes from a boy with Bloom's syndrome and a man with xeroderma pigmentosum.

Authors:  H J Evans; A C Adams; J M Clarkson; J German
Journal:  Cytogenet Cell Genet       Date:  1978

9.  Excision repair in ataxia telangiectasia, Fanconi's anemia, Cockayne syndrome, and Bloom's syndrome after treatment with ultraviolet radiation and N-acetoxy-2-acetylaminofluorene.

Authors:  F E Ahmed; R B Setlow
Journal:  Biochim Biophys Acta       Date:  1978-12-21

10.  Sensitivity of Bloom's syndrome lymphocytes to ethyl methanesulfonate.

Authors:  A B Krepinsky; J A Heddle; J German
Journal:  Hum Genet       Date:  1979       Impact factor: 4.132

View more
  13 in total

Review 1.  Human DNA repair defects.

Authors:  C F Arlett
Journal:  J Inherit Metab Dis       Date:  1986       Impact factor: 4.982

2.  Genetic changes in mammalian cells reminiscent of an SOS response.

Authors:  P Herrlich; U Mallick; H Ponta; H J Rahmsdorf
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

3.  Chromosome breakage factor in the plasma of two Bloom's syndrome patients.

Authors:  I Emerit; P A Cerutti; A Levy; P Jalbert
Journal:  Hum Genet       Date:  1982       Impact factor: 4.132

4.  Clastogenic factors as potential biomarkers of increased superoxide production.

Authors:  Ingrid Emerit
Journal:  Biomark Insights       Date:  2007-12-11

5.  DNA ligase activity in human cell lines from normal donors and Bloom's syndrome patients.

Authors:  M Mezzina; J Nardelli; S Nocentini; G Remault; A Sarasin
Journal:  Nucleic Acids Res       Date:  1989-04-25       Impact factor: 16.971

6.  Protease inhibitors reduce the frequency of spontaneous chromosome abnormalities in cells from patients with Bloom syndrome.

Authors:  A R Kennedy; B S Radner; H Nagasawa
Journal:  Proc Natl Acad Sci U S A       Date:  1984-03       Impact factor: 11.205

7.  12-O-tetradecanoylphorbol 13-acetate-inducible proteins are synthesized at an increased rate in Bloom syndrome fibroblasts.

Authors:  U Mallick; H J Rahmsdorf; N Yamamoto; H Ponta; R D Wegner; P Herrlich
Journal:  Proc Natl Acad Sci U S A       Date:  1982-12       Impact factor: 11.205

8.  Tumor promoter phorbol 12-myristate 13-acetate induces a clastogenic factor in human lymphocytes.

Authors:  I Emerit; P A Cerutti
Journal:  Proc Natl Acad Sci U S A       Date:  1982-12       Impact factor: 11.205

9.  Transferable clastogenic activity in plasma from patients with Fanconi anemia.

Authors:  I Emerit; A Levy; G Pagano; L Pinto; R Calzone; A Zatterale
Journal:  Hum Genet       Date:  1995-07       Impact factor: 4.132

10.  The effect of aphidicolin on the rate of DNA replication and unscheduled DNA synthesis of Bloom syndrome and normal fibroblasts.

Authors:  F Giannelli; P K Botcherby; J A Avery
Journal:  Hum Genet       Date:  1982       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.